Literature DB >> 32120024

Ectopic HOTTIP expression induces noncanonical transactivation pathways to promote growth and invasiveness in pancreatic ductal adenocarcinoma.

Chi Hin Wong1, Chi Han Li1, Qifang He1, Stephen Lam Chan2, Joanna Hung-Man Tong3, Ka-Fai To3, Li-Zhu Lin4, Yangchao Chen5.   

Abstract

HOXA transcript at the distal tip (HOTTIP), a long noncoding RNA, is upregulated in pancreatic ductal adenocarcinoma (PDAC), but the HOTTIP-mediated oncogenic pathway is not fully understood. We identified canonical HOTTIP-HOXA13 targets, CYP26B1, CLIC5, CHI3L1 and UCP2-responsible for cell growth and cell invasion. Genome-wide analysis revealed that 38% of HOTTIP-regulated genes contain H3K4me3 and HOTTIP enrichment at their promoters, without HOXA13 binding. HOTTIP complexes with WDR5-MLL1 to trans-activate oncogenic proteins CYB5R2, SULT1A1, KIF26A, SLC1A4, and TSC22D1 by directly inducing H3K4me3 at their promoters. The WDR5, MLL1, and H3K4me3 levels at their promoters and their expression levels are sensitive to HOTTIP expression. These results indicate the importance of the noncanonical trans-acting HOTTIP-WDR5-MLL1 pathway in the HOTTIP regulatory mechanism by promoting oncogenic protein expression. Furthermore, HOTTIP is regulated by miR-497 in PDAC cells, but HOTTIP is negatively correlated with miR-497 levels in PDAC tissues. In conclusion, HOTTIP is upregulated in PDAC due to the loss of the inhibitory miR-497; HOTTIP promotes PDAC progression through the canonical HOTTIP-HOXA13 axis. A novel noncanonical trans-acting HOTTIP-WDR5-MLL1-H3K4me3 pathway is also delineated.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HOTTIP; HOTTIP–WDR5–MLL1–H3K4me3; HOXA13; Pancreatic cancer; miR–497

Mesh:

Substances:

Year:  2020        PMID: 32120024     DOI: 10.1016/j.canlet.2020.02.038

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  The establishment of CDK9/RNA PolII/H3K4me3/DNA methylation feedback promotes HOTAIR expression by RNA elongation enhancement in cancer.

Authors:  Chi Hin Wong; Chi Han Li; Joanna Hung Man Tong; Duo Zheng; Qifang He; Zhiyuan Luo; Ut Kei Lou; Jiatong Wang; Ka-Fai To; Yangchao Chen
Journal:  Mol Ther       Date:  2022-02-02       Impact factor: 12.910

Review 2.  Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance.

Authors:  Jiajia Li; Sicong Hou; Ziping Ye; Wujun Wang; Xiaolin Hu; Qinglei Hang
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

3.  LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.

Authors:  Chao Guo; Ya-Yue Gao; Qian-Qian Ju; Chun-Xia Zhang; Ming Gong; Zhen-Ling Li
Journal:  BMC Cancer       Date:  2020-09-03       Impact factor: 4.430

4.  CircRTN4 promotes pancreatic cancer progression through a novel CircRNA-miRNA-lncRNA pathway and stabilizing epithelial-mesenchymal transition protein.

Authors:  Chi Hin Wong; Ut Kei Lou; Frederic Khe-Cheong Fung; Joanna H M Tong; Chang-Hua Zhang; Ka-Fai To; Stephen Lam Chan; Yangchao Chen
Journal:  Mol Cancer       Date:  2022-01-04       Impact factor: 27.401

Review 5.  Regulation of Hippo, TGFβ/SMAD, Wnt/β-Catenin, JAK/STAT, and NOTCH by Long Non-Coding RNAs in Pancreatic Cancer.

Authors:  Ammad Ahmad Farooqi; Sawera Nayyab; Chiara Martinelli; Rossana Berardi; Hector Katifelis; Maria Gazouli; William C Cho
Journal:  Front Oncol       Date:  2021-06-09       Impact factor: 6.244

6.  Knockdown of lncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer via Sponging miR-1231.

Authors:  Bowei Liu; Wei Wang; Suofeng Sun; Hui Ding; Ling Lan; Xiuling Li; Shuangyin Han
Journal:  Onco Targets Ther       Date:  2020-11-05       Impact factor: 4.147

Review 7.  Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma.

Authors:  Jieyu He; Lin Ling; Zhongyue Liu; Xiaolei Ren; Lu Wan; Chao Tu; Zhihong Li
Journal:  Cancer Cell Int       Date:  2021-06-15       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.